Synopsis
Motivation:
Goals:
Approach:
Results:
463-05-011
ISMRM Abstract
Improved Diagnosis of Prostate Cancer Through Native Integration of Hybrid Multi-Dimensional MRI With PSMA-PET
Accepted
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
Log inReferences
1. Westphalen AC, McCulloch CE, Anaokar JM, Arora S, Barashi NS, Barentsz JO, et al. Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel. Radiology. 2020;296(1):76-84. doi: 10.1148/radiol.2020190646. PubMed PMID: 32315265. [doi] [pmid]
2. Chatterjee A, Gallan AJ, He D, Fan X, Mustafi D, Yousuf A, et al. Revisiting quantitative multi-parametric MRI of benign prostatic hyperplasia and its differentiation from transition zone cancer. Abdom Radiol. 2019;44(6):2233-43. doi: 10.1007/s00261-019-01936-1. [doi]
3. Chatterjee A, Yousuf AN, Engelmann R, Harmath C, Lee G, Medved M, et al. Prospective Validation of an Automated Hybrid Multidimensional MRI Tool for Prostate Cancer Detection Using Targeted Biopsy: Comparison with PI-RADS-based Assessment. Radiol Imaging Cancer. 2025;7(1):240156. doi: 10.1148/rycan.240156. [doi]
4. Emmett L, Buteau J, Papa N, Moon D, Thompson J, Roberts MJ, et al. The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study. European Urology. 2021;80(6):682-9. doi: https://doi.org/10.1016/j.eururo.2021.08.002. [doi]
5. Woo S, Becker AS, Leithner D, Mayerhoefer ME, Friedman KP, Tong A, et al. Discordance between prostate MRI and PSMA-PET/CT: the next big challenge for primary prostate tumor assessment? European Radiology. 2025;35(7):4043-54. doi: 10.1007/s00330-025-11358-x. [doi]
6. Dhar A, Mendez L, Cendejas-Gomez JdJ, Boldt G, McArthur E, Zamboglou C, et al. Detection and delineation of intraprostatic lesions (IPLs) using multiparametric magnetic resonance imaging (mpMRI) and prostate specific membrane antigen positron emission tomography (PSMA PET) for patients with prostate cancer: A systematic review and meta-analysis. Journal of Clinical Oncology. 2024;42(4_suppl):287-. doi: 10.1200/JCO.2024.42.4_suppl.287. [doi]
7. Chatterjee A, Bourne R, Wang S, Devaraj A, Gallan AJ, Antic T, et al. Diagnosis of Prostate Cancer with Noninvasive Estimation of Prostate Tissue Composition by Using Hybrid Multidimensional MR Imaging: A Feasibility Study. Radiology. 2018;287(3):864-72. doi: 10.1148/radiol.2018171130. [doi]
8. Chatterjee A, Mercado C, Bourne R, Yousuf A, Hess B, Antic T, et al. Validation of prostate tissue composition using Hybrid Multidimensional MRI: Correlation with histology. Radiology. 2021;2022(302(2)):368-77. doi: 10.1148/radiol.2021204459. [doi]
9. Wright GL, Jr., Haley C, Beckett ML, Schellhammer PF. Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues. Urologic oncology. 1995;1(1):18-28. doi: 10.1016/1078-1439(95)00002-y. [doi]
Cite this abstract
http://echo.ismrm.org/p/ISMRM2026/463-05-011